“…Since intrabody was successfully captured in the lumen of the ER by KDEL ER-retention signal sequence, it is possible that the intrabody binds to CD147 and retains these molecules in the membrane of the ER compartment and subsequently diminishes CD147 expression on the cell surface. In other studies, targeting of intrabodies to the ER has been successfully applied to knockdown major histocompatibility complex I (MHC-I) expression (Mhashilkar et al, 2002;Beyer et al, 2004;Zdoroveac et al, 2008) and inactivate various neoplastic cell-surface receptors (Wheeler et al, 2003;Jendreyko et al, 2005;Peng et al, 2007). Additionally, the same strategy was used to block cell surface expression of the CCR5 receptor which is important for cell entry of HIV-1 (Steinberger et al, 2000).…”